Close

Actinium Pharma (ATNM) Reports Promising Data on Labeling of Daratumumab with Radioisotope Actinium-225

December 12, 2017 7:33 AM EST Send to a Friend
Actinium Pharmaceuticals, Inc. (NYSE: ATNM), presented data at the 59th Annual American Society of Hematology (ASH) Meeting & Exposition on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login